Intravenous Immunoglobulin Market to Witness Huge Growth by Key Players: CSL Ltd., Grifols, S.A., Octapharma AG, Kedrion Biopharma Inc.

Rise in demand for biopharmaceuticals and increase in R&D expenditure for biopharmaceutical companies drive the growth of the global downstream processing market.  On the other hand, dearth and shortage of skilled bioprocess engineers restrain the growth to some extent. However, emerging markets such as China and India offer lucrative opportunities in the industry. The main factors driving …

Intravenous Immunoglobulin Market is projected to reach $15,964 million by 2025, registering a CAGR of 7.5%

According to the report by Allied Market Research, titled, “Intravenous Immunoglobulin (IVIG) Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre syndrome, and Others) and Type (IgG, IgA, IgM, IgE, and IgD): Global Opportunity Analysis and Industry Forecast, 2018 – 2025”. The …

Intravenous Immunoglobulin Market Growing Trade Among Emerging Economies Opening New Opportunities 2022-2025

The global IVIG market is driven by factors such as high prevalence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia coupled with surge in geriatric population and rise in the number of hemophilic patients. In addition, increase in production of immunoglobulin with better plasma quality using advanced purification techniques is expected to …

Intravenous Immunoglobulin Market Size, Growth Opportunities, Current Trends and Future Scenarios till 2025

Is all IVIG the same? There are a number of different brands of IVIG. They differ in the details of how they are produced. In general, if you are going to be receiving IVIG on a regular basis, it may be best to use the same brand every time to reduce the risk of side …